Digital Therapeutics #DTx are an emerging class of medicines that deliver evidence-based therapeutic interventions to patients.
In a similar way to the drug, we can identify in the composition of DTx both active ingredients and excipients, in a digital form.
There are many open points and grey areas on the modalities of research, development and clinical trials of DTx and they can only be addressed through experience and continuous discussion, involving all stakeholders and institutions.
DTxDay2020 will provide answers to some of the open questions and guidelines for the development and entry into medical practice of Digital Therapies.
DTxDay2020 also aims to raise awareness among public and private health and business institutions about this new health technology at an early stage of development and the opportunities that our country can seize through its involvement in its research and development, as a necessary condition to play a leading role in the global development of digital health.